Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Eton Pharmaceuticals Inc ETON

Healthcare Drug Manufacturers - Specialty & Generic
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency... see more

Current News (NDAQ:ETON)

Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th

GlobeNewswire November 24, 2025

Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th

GlobeNewswire November 12, 2025

Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results

GlobeNewswire November 6, 2025

Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

GlobeNewswire October 23, 2025

Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference

GlobeNewswire August 20, 2025

Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results

GlobeNewswire August 7, 2025

Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025

GlobeNewswire July 28, 2025

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)

GlobeNewswire July 8, 2025

Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes

GlobeNewswire June 27, 2025
View More News ››

Opinion & Analysis (NDAQ:ETON)

Eton Pharma Shares Climb 20% After Firm Secures US Rights for Pediatric Kidney Disease Drug

Streetwise Reports March 30, 2020
View More Opinion ››

Bullboard Posts (NDAQ:ETON)

Using technical analysis for this stock.

This stock should be going up this morning
coolfooldumbguy - March 14, 2025

Eton Pharmaceuticals, Inc. (NASDAQ:ETON): Delivering Consist

http://beyondspx.com/2024/08/01/eton-pharmaceuticals-inc-nasdaqeton-delivering-consistent-growth-and-advancing-late-stage-pipeline/
MikeTester - August 2, 2024
View more Bullboard ››

TomaGold Corp.

TomaGold Corp.

TomaGold Corporation, together with its subsidiaries, engages in the acquisition, exploration, assessment, and development of ...
View More »